ClinicalTrials.Veeva

Menu

Genetic Biomarkers of Child Language Development in Taiwan: an Identification and Validation Study

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Enrolling

Conditions

Child Language

Treatments

Genetic: The experiment does not required any intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05504564
202102436A3

Details and patient eligibility

About

A study of the relation between genetic biomarkers and child language development in Taiwan.

Full description

The interaction between gene and environment (G×E) can be a very complicated process that influences child development. As a pilot study of child development biomarkers, this study investigates genes related to child language development and language disorder.

Enrollment

300 estimated patients

Sex

All

Ages

2 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 2-18 y/o
  • Agree to sign informed consent

Exclusion criteria

  • Central nervous system disease
  • Neuromuscular Disorders
  • Congenital Abnormality
  • Genetic Disease
  • Dysesthesia
  • Hearing Impairment

Inclusion Criteria of Child with language disorder:

  • Patients with Language Disorder
  • Age 2-18 y/o
  • Agree to sign informed consent
  • Exclusion Criteria of Child with language disorder:
  • Hearing Impairment

Inclusion Criteria of Adult:

  • His or her child participated in this study, and gene abnormality was found.

Trial design

300 participants in 2 patient groups

Control group
Description:
healthy child
Experimental group
Description:
parents with language disorder
Treatment:
Genetic: The experiment does not required any intervention

Trial contacts and locations

1

Loading...

Central trial contact

Chia-Ling Chen, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems